|
RNF19A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.214400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.964800E-01 |
| Normal-vs-Stage2 |
2.562800E-01 |
| Normal-vs-Stage3 |
7.806000E-01 |
| Normal-vs-Stage4 |
6.471800E-01 |
| Stage1-vs-Stage2 |
5.658800E-01 |
| Stage1-vs-Stage3 |
4.993000E-01 |
| Stage1-vs-Stage4 |
9.199000E-01 |
| Stage2-vs-Stage3 |
3.328400E-01 |
| Stage2-vs-Stage4 |
6.238600E-01 |
| Stage3-vs-Stage4 |
7.863600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.147000E-01 |
| Normal-vs-AfricanAmerican |
9.366200E-01 |
| Normal-vs-Asian |
6.563400E-01 |
| Caucasian-vs-AfricanAmerican |
5.784400E-01 |
| Caucasian-vs-Asian |
8.280600E-01 |
| AfricanAmerican-vs-Asian |
6.270400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.396000E-01 |
| Normal-vs-Female |
9.262100E-02 |
| Male-vs-Female |
9.899600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.499400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.411000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.198800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.141400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.247800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.524300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.858560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.538000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.992000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.210800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.568100E-02 |
| Normal-vs-Grade 2 |
1.528610E-01 |
| Normal-vs-Grade 3 |
4.019000E-01 |
| Normal-vs-Grade 4 |
2.939400E-01 |
| Grade 1-vs-Grade 2 |
3.597000E-01 |
| Grade 1-vs-Grade 3 |
1.769960E-01 |
| Grade 1-vs-Grade 4 |
3.516500E-02 |
| Grade 2-vs-Grade 3 |
6.553200E-01 |
| Grade 2-vs-Grade 4 |
2.388200E-02 |
| Grade 3-vs-Grade 4 |
7.676300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.283700E-02 |
| Normal-vs-ccB subtype |
9.322400E-01 |
| ccA subtype-vs-ccB subtype |
1.991800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.570200E-01 |
| Normal-vs-N1 |
9.348000E-01 |
| N0-vs-N1 |
7.277600E-01 |
|
|
